Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study ARGX-117
Principal Investigator
Co-Investigator(s)
Related Studies
GXCA
Investigator: Lawrence Dickinson, M.D
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD